key: cord-0925276-g6rg9tyb
authors: Kario, Kazuomi
title: HOPE Asia Network Activity 2021—Collaboration and perspectives of Asia academic activity
date: 2021-02-17
journal: J Clin Hypertens (Greenwich)
DOI: 10.1111/jch.14215
sha: 6515f6631bf490b872b2e09d97195532acf6ad87
doc_id: 925276
cord_uid: g6rg9tyb

nan

Despite the challenging year, the HOPE Asia Network has continued to work toward the goal of improving the management of hypertension and organ protection to achieve "zero" cardiovascular events in Asia. 3, 4 Specifically related to the pandemic, the group issued guidance on COVID-19 and hypertension to help inform clinical management. 5 In addition, the fruits of academic efforts under unparalleled circumstances are reflected in this issue. This includes several HOPE Asia Network documents. These cover practice points relating to implementation of ambulatory blood pressure (BP) monitoring in clinical practice, a review of mental health problems and hypertension in the elderly, the current status of adherence interventions for hypertension management, a comprehensive review of the association between hypertension and stroke in Asia, and discussion around the development of Asia-specific tools for cardiovascular risk assessment. Measurement of BP in the clinic is the subject of another review, which highlights approaches to improve the ease and accuracy of this important parameter in subjects with hypertension.

Overall, the characteristics and consequences of hypertension in subjects from Asia differ in several important ways from those in Western populations. The clinical significance of nocturnal hypertension in Asia and the use of nocturnal home BP monitoring to improve patient management are discussed in this issue. There is also a closer look within Asia itself, highlighting ethnic differences in genetic variants, dietary choice, and lifestyle habits, along with sociodemographic differences, and variations in hypertension awareness and treatment control. Differences in culture, foods, and environment could contribute to different profiles of cardiovascular risk between Asian countries. This was highlighted by the results of a clinical study in this issue, which showed substantial differences in 24-hour BP profiles even between neighboring countries in Asia (Japan and Thailand). In a study from Thailand, stroke was found to be the most common target organ damage in subjects with hypertensive emergency (consistent with stroke being a more common complication of hypertension in Asian subjects than coronary artery disease). 6, 7 Isolated systolic hypertension (ISH) is the most common form of hypertension in the elderly and young adults. With rapid population aging in the Asia region, the prevalence of ISH will rise substantially. 

One important feature of hypertension in Asian populations is high nighttime BP due to high salt sensitivity and salt intake. 4 

The Asian characteristics of hypertension mean that some approaches to treatment might be more effective than others. Specific treatments reviewed in the current issue include the use of betablockers in the region using data from the AsiaBP@Home study, 9 the angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan), and the feasibility and utility of a polypill for cardiovascular disease prevention in Asian populations. Local clinical trial data on some alternatives to pharmacological therapy (foot reflexology and pursed-lip breathing combined with number counting) provide some interesting options to consider.

Hypertension is an important cardiovascular risk factor. A study presented in this issue showed that algorithms that rely on ICD-10 diagnosis codes in combination with data on specific drugs and medical 

World Health Organization. The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment

Information note on COVID-19 and NCDs

The HOPE Asia Network activity for "zero" cardiovascular events in Asia: Overview 2020

Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network

COVID-19 and hypertension-evidence and practical management: guidance from the HOPE Asia Network

Global variation in the relative burden of stroke and ischemic heart disease

Cardiovascular disease and risk factors in Asia: a selected review

NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Home blood pressure control status in 2017-2018 for hypertension specialist centers in Asia: results of the Asia BP@Home study

Salt consumption and the risk of chronic diseases among Chinese adults in Ningbo city

Management of hypertension in the digital era: small wearable monitoring devices for remote blood pressure monitoring

Highly precise risk prediction model for new-onset hypertension using artificial intelligence techniques

Prediction of blood pressure variability using deep neural networks

How to cite this article: Kario K. HOPE Asia Network Activity 2021-Collaboration and perspectives of Asia academic activity